Ja-Hong Kim

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.

S. Shariat, W. Benedict, S. Lerner, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive value of expression of transforming growth factor‐β1 and its receptors in transitional cell carcinoma of the urinary bladder

T. Wheeler, S. Shariat, S. Lerner, 2001, Cancer.

Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

M. Kattan, T. Wheeler, S. Shariat, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.

W. Benedict, S. Lerner, G. Ayala, 2003, The Journal of urology.

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.

T. Wheeler, S. Shariat, S. Lerner, 2003, The Journal of urology.

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.

S. Shariat, S. Lerner, G. Ayala, 2003, Urology.